文章
醫療新知 > 發現癌症新療法 加國博士生獲Mitacs傑出獎

發現癌症新療法 加國博士生獲Mitacs傑出獎

25-11-2017

加拿大安省女王大學博士生米倫(Caitlin Miron),因發現了一組新奇、有可能「切斷」癌細胞並阻止它們擴散的DNA組合,榮獲Mitacs傑出創新博士獎(Mitacs Award for Outstanding Innovation-PhD)。

現年28歲的米倫發現的這一全新DNA組合,屬核酸G-四鏈體(guanine quadruplex),不僅與癌症細胞有關,也與導致艾滋病毒等其他疾病的細胞有關。這意味著,新發現有可能有效阻止癌症及艾滋病細胞的生長和擴散。

米倫對global news表示, 新發現是研究人員20多年來夢寐以求的。她說,大多數人所熟悉的DNA為雙螺旋結構,但它可在短暫時間內以單鏈形式存在。

她以項鍊來形容她的新發現。想像一下珠子在鍊子上自由移動,在項鍊打結的地方就會停下來。過去10年間,研究人員已經了解到,這些「結」與致癌基因(oncogenes)息息相關。不幸的是,這些「結」可以解開,導致癌症發展並擴散。

新發現將使把「結」固定住,並阻止「珠子」移動至導致癌症發展並擴散的DNA區域。米倫補充道,新發現還可能對導致艾滋病感染的DNA區域的四鏈體產生極大作用。

預計兩年至八年內,製藥公司就能夠獲准生產相關藥物。

http://www.epochtimes.com/b5/17/11/23/n9886535.htm

 

 

 

Canadian PhD student makes groundbreaking cancer discovery

 

 

A PhD candidate at Queen’s University has discovered a novel DNA binder that could “switch off” cancer cells and prevent them from spreading.

Through screening numerous chemical compounds, Caitlin Miron, 28, identified one compound that binds to a four-strand DNA structure called a guanine quadruplex that’s associated with cancer and other diseased cells. The compound could be effective in targeting cancer cells and prevent their growth and metastasis. It could also be applied to other diseases including HIV.

WATCH: Caitlin Miron receives the Mitacs Award for Outstanding Innovation – PhD in Ottawa.

In an interview with Global News, Miron described her discovery using an analogy of a single-strand necklace. Most people are familiar with DNA as a double-helix structure, she says, but it can temporarily become a single strand.“It’s incredibly exciting because researchers have been trying to identify DNA binders with properties like this one for more than two decades,” Miron said in a statement. “It’s so new, we’ve had to devise our own techniques for analysing and testing it.”

“Think of a necklace as a DNA chain and imagine beads that move freely down the chain until they hit a knot in the necklace,” she said. “The beads moving down are the cell machinery that’s going to process parts of the DNA, and translate it to proteins that will have [cancerous] effects in cells and tissues.”

Over the course of the last 10 years, researchers have learned that these “knots” form before areas called oncogenes, genes that produce proteins that can contribute to cancer development and metastasis. Unfortunately, the “knots” can be untangled.

“We’ve essentially found a superglue that keeps the ‘knots’ in place and prevents the ‘beads’ from reaching the section of DNA where they can grow and spread cancer cells.”

 

She says that this compound could also have a high impact on a quadruplex in a part of the HIV DNA that’s responsible for infection.

It is expected that the compound will be ready for licensing by pharmaceutical companies anywhere from two to eight years from now, and early results from the U.S. National Cancer Institute have been positive.

“We are seeing therapeutic benefits in that cancer growth is reduced in some of the cell lines,” Miron said. “The next step is to determine the best way to adapt this compound for use in humans.”

Miron, who has been working under the supervision of Dr. Anne Petitjean at Queen’s University and Dr. Jean-Louis Mergny at the European Institute of Chemistry and Biology in Bordeaux, was honoured with the Mitacs Award for Outstanding Innovation – PhD yesterday in Ottawa.

https://globalnews.ca/news/3874569/canadian-student-cancer-discovery/

城中活動

2022-03-01 10:00 上午 椅子操
2022-02-23 7:00 下午 乳龍工作坊

疑難排解

會員註冊


或許你會想看
(重磅新聞) ASCO2021值得關注的臨床腫瘤學科研成果
ASCO2021值得關注的臨床腫瘤學科研成果 [醫藥新聞] 美國臨床腫瘤學會(ASCO)代表所有關心癌症患者的 […]
港大醫學院發現肝癌細胞耐藥性及腫瘤復發的新分子機制
港大醫學院發現肝癌細胞耐藥性及腫瘤復發的新分子機制 2021年06月01日 港大醫學院發現肝癌細胞耐藥性及腫瘤 […]
中大研究發現半數受訪兒童癌症康復者曾使用替代補充療法 或存在「藥療相互作用」風險
中大研究發現半數受訪兒童癌症康復者曾使用替代補充療法 或存在「藥療相互作用」風險 2021年6月1日 負責是次 […]
中大醫學院兩學者榮膺「2019年全球20位頂尖轉化研究科學家」 榜上唯一亞洲學府 盧煜明教授連續第四年獲選 2020年10月29日
中大醫學院兩學者榮膺「2019年全球20位頂尖轉化研究科學家」 榜上唯一亞洲學府 盧煜明教授連續第四年獲選 2 […]
港大醫學院發現Vδ2-T細胞外泌體 可作為治療EB病毒相關腫瘤的新方法
港大醫學院發現Vδ2-T細胞外泌體 可作為治療EB病毒相關腫瘤的新方法 2020年10月08日 港大醫學院發現 […]
精靈一點訪問-肺癌免疫治療
主題:肺癌免疫治療 嘉賓:吳偉麟(癌症資訊網創辦人)、潘智文醫生(臨床腫瘤科專科醫生)   相關文章 […]
雄激素阻斷療法(androgen deprivation therapy,ADT)或保護前列腺癌患者免受COVID-19感染
雄激素阻斷療法(androgen deprivation therapy,ADT)或保護前列腺癌患者免受COV […]